View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
May 6, 2021

Quidel partners with Walgreens to further sale of Covid-19 test kits

Quidel has partnered with drugstore chain Walgreens to make QuickVue at-home rapid antigen tests available without a prescription.

The retail partnership will allow Walgreens to make Quidel’s non-prescription QuickVue at-home over-the-counter (OTC) Covid-19 tests available at 7,600 Walgreens stores in the US and Puerto Rico.

Moreover, consumers will also have the option to order the shelf-stable packages online at for store pick-up or same-day delivery.

Each package contains two of the self-administered rapid antigen tests.

Quidel president and CEO Douglas Bryant said: “This retail collaboration with Walgreens will expedite in-store availability and over-the-counter sales of our QuickVue at-home OTC Covid-19 antigen tests to consumers nationwide.”

Although the QuickVue at-home OTC Covid-19 test has not been approved by the US Food and Drug Administration (FDA), it can be used under the FDA’s emergency use authorisation.

In a press statement, Quidel said: “The QuickVue at-home Covid-19 test shows excellent performance, with positive results agreeing with PCR 83.5% of the time, and negative results agreeing 99.2% of the time, delivering confidence to individuals running the test and helping to prevent asymptomatic virus spread.”

Last month, Quidel signed a distribution and fulfilment agreement with McKesson to improve access to the QuickVue at-home OTC COVID-19 test for consumers.

McKesson will serve as the lead commercial partner for Quidel’s at-home OTC COVID-19 rapid antigen test orders.

Using the QuickVue OTC Covid-19 test, consumers can get highly accurate results in ten minutes or less from nasal swab samples, Quidel said.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network